Sensei Biotherapeutics enters at-the-market equity distribution agreement for up to $150 million stock salePUBT·Jun 18 at 04:13 PMSNSE0.00%TD+2.37%
Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer | FTH Stock NewsStockTitan·Jun 14 at 11:10 PMSNSE0.00%FTH-0.38%
Top Biotech Gainers: SNSE Awaits Data In 2H, STTK To Begin Crohn's Trial In Q3, ALMS On Watchrttnews·Jun 14 at 09:09 PMALMS+9.74%TXMD-1.46%
This Daktronics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursdaybenzinga_article·Jun 11 at 06:17 AMDHR-0.16%TMO+5.00%
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | SNSE Stock NewsStockTitan·Jun 4 at 07:00 AMSNSE0.00%FTH-0.38%
Dual Insider Moves Shake Up Sensei Biotherapeutics Investor WatchTip Ranks·Jun 1 at 09:12 PMSNSE0.00%FTH-0.38%
Sensei Biotherapeutics Insiders Sold Shares Worth Over $1.0MTradingView·Jun 1 at 04:30 PMSNSE0.00%FTH-0.38%
Top Biotech Gainers: REPL On Track, SNSE Awaits Phase 2 Data, Keep An Eye On CCCC, IMRX Soarsrttnews·May 31 at 09:33 PMCMND+10.96%REPL0.00%
Sensei Biotherapeutics shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating.benzinga_article·May 29 at 11:43 AMSNSE0.00%FBT+0.87%
Sensei Biotherapeutics to Convert Series B Preferred, Pro Forma Shows 25.7M Shares and $184.6M EquityTradingView·May 21 at 04:13 PMSNSE0.00%ARKG+4.69%
Sensei Biotherapeutics (NASDAQ:SNSE) Major Shareholder Millennium Management Llc Sells 8,151 SharesMarket Beat·May 16 at 06:43 AMSNSE0.00%FTH-0.38%
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga_article·May 15 at 04:06 PMARAY+23.43%SNSE0.00%
Sensei Biotherapeutics reports $170.2M Q1 net loss, $202.8M cash positionTradingView·May 15 at 06:43 AMSNSE0.00%FBT+0.87%
